Foscarnet therapy for cytomegalovirus infection after allogeneic bone marrow transplantation

Clin Infect Dis. 1996 Mar;22(3):583-4. doi: 10.1093/clinids/22.3.583.
No abstract available

MeSH terms

  • Bone Marrow Transplantation / adverse effects*
  • Cytomegalovirus Infections / drug therapy*
  • Cytomegalovirus Infections / virology
  • Foscarnet / therapeutic use*
  • Humans
  • Prospective Studies
  • Transplantation, Homologous

Substances

  • Foscarnet